Crescendo Biologics is a biopharmaceutical company developing potent, truly differentiated mono- and multi-functional Humabody® therapeutics in oncology.
The Company’s Humabody® therapeutics are based on its unique, patent protected, transgenic mouse platform generating 100% human VH domain building blocks (Humabody® VH) with superior biophysical properties and developability.
Crescendo is pursuing novel Humabody®-based product opportunities, through in-house development and strategic partnerships in both multi-specific immuno-oncology modulators and Humabody® Drug Conjugates (HDCs), the next generation of ADCs.